TQR Stock Overview
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.98 |
| 52 Week High | HK$1.19 |
| 52 Week Low | HK$0.81 |
| Beta | 0.46 |
| 1 Month Change | 3.16% |
| 3 Month Change | -1.51% |
| 1 Year Change | -17.65% |
| 3 Year Change | -20.97% |
| 5 Year Change | -10.91% |
| Change since IPO | 6.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| TQR | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 1.6% | -7.1% | 0.8% |
| 1Y | -17.6% | -27.3% | 15.0% |
Return vs Industry: TQR exceeded the German Pharmaceuticals industry which returned -27.8% over the past year.
Return vs Market: TQR underperformed the German Market which returned 14.4% over the past year.
Price Volatility
| TQR volatility | |
|---|---|
| TQR Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: TQR has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: TQR's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 782 | Wang Chi | cm.tongrentang.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
| TQR fundamental statistics | |
|---|---|
| Market cap | €823.69m |
| Earnings (TTM) | €56.91m |
| Revenue (TTM) | €183.33m |
Is TQR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TQR income statement (TTM) | |
|---|---|
| Revenue | HK$1.61b |
| Cost of Revenue | HK$546.32m |
| Gross Profit | HK$1.07b |
| Other Expenses | HK$565.05m |
| Earnings | HK$500.28m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.60 |
| Gross Margin | 66.10% |
| Net Profit Margin | 31.04% |
| Debt/Equity Ratio | 0.005% |
How did TQR perform over the long term?
See historical performance and comparisonDividends
Does TQR pay a reliable dividends?
See TQR dividend history and benchmarks| Beijing Tong Ren Tang Chinese Medicine dividend dates | |
|---|---|
| Ex Dividend Date | Jun 05 2025 |
| Dividend Pay Date | Jun 18 2025 |
| Days until Ex dividend | 15 days |
| Days until Dividend pay date | 28 days |
Does TQR pay a reliable dividends?
See TQR dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 17:53 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Beijing Tong Ren Tang Chinese Medicine Company Limited is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yanyin Zhu | China International Capital Corporation Limited |
| null null | CMB International Securities Limited |
| Zhou Chen | HSBC |